We examined across different SCLC patient tissues and consistent with precious results, we found patients with higher IGF-1R expression tumors had a poorer survival rate (Fig 1b), suggesting a potential therapeutic value of CP to target SCLC. Here, IGF1R is linked to small cell lung carcinoma.